StreetAlpha
13F holdings · Q3 2026

Cormorant Asset Management

Boston, MA · files as Cormorant Asset Management, LP
Know the moment Cormorant Asset Management filesYou follow Cormorant Asset Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1583977

Cormorant Asset Management reported 60 stocks worth $1.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PBLS (10.0%), PRAX (9.8%) and RAPP (5.5%). Compared with Q2 2026, the fund opened new positions in BLSM, ETRA and ATTO, added to AMLX, trimmed PRAX, RAPP and EWTX and sold out of ALT.

Latest filing: what Cormorant Asset Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
13 new1 added36 trimmed3 sold outBought about $291M · sold about $353M
New 13
See all 13 →
Added 1
Trimmed 36
See all 36 →
Sold out 3
  • Galecto Inc$26M
  • Crinetics Pharmace$4.7M
  • ALT$3.8M

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.5B−23.7% vs last quarter
Stocks held6013 new · 3 sold out
Top 5 weight35.3%fairly concentrated
Turnover43%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
PBLS
Parabilis Medicines Inc Com
$149M10.0%4.6MNo change2 of 8
2
PRAX
Praxis Precision Medicines I
$146M9.8%500K−140K (−22%)8 of 8
3
RAPP
Rapport Therapeutics Inc
$82.6M5.5%2.5M−200K (−8%)8 of 8
4
EWTX
Edgewise Therapeutics Inc
$75.5M5.1%1.9M−650K (−26%)8 of 8
5
BBOT
Bridgebio Oncology Therapeut
$73.3M4.9%17.9MNo change5 of 8
6
ERAS
Erasca Inc
$73.3M4.9%5M−1M (−17%)3 of 8
7
BLSM
Blossomhill Therapeutics Inc
$67.4M4.5%3.6MNew position1 of 8
8
ANL
Adlai Nortye Ltd
$63.7M4.3%4MNo change3 of 8
9
DNTH
Dianthus Therapeutics Inc
$44M3.0%500K−250K (−33%)3 of 8
10
ABVX
Abivax SA
$42.1M2.8%425K−250K (−37%)8 of 8
🔒 50 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
GALECTO INC
$26M1M
CRINETICS PHARMACEUTICALS IN
$4.7M125K
ALT
Altimmune Inc
$3.8M1.3M

Reported value

last 8 quarters
$1.8BQ4 '24
$1.3BQ1 '25
$1.3BQ2 '25
$1.4BQ3 '25
$1.8BQ4 '25
$2BQ1 '26
$2BQ2 '26
$1.5BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Cormorant Asset Management 13F FAQ

What does Cormorant Asset Management own?

Cormorant Asset Management reported 60 stocks worth $1.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PBLS (10.0%), PRAX (9.8%) and RAPP (5.5%). The table above lists every position in the filing (the top 10 without an account).

What did Cormorant Asset Management buy and sell in Q3 2026?

Compared with Q2 2026: 13 new positions, 1 added to, 36 trimmed and 3 sold out. New positions include BLSM, ETRA and ATTO. It sold all of ALT.

When will Cormorant Asset Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Cormorant Asset Management's portfolio worth?

The Q3 2026 filing reports $1.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.